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EARLY FAILURE OF FREEHAND AORTIC STENTLESS XENOGRAFT VALVES 
Giovanni Battista Luciani, MD, Paolo Bertolini, MD, and Alessandro Mazzucco, MD, Verona, Italy 
The evidence of suboptimal hemodynamics and of 
limited durability of stented porcine bioprostheses has 
promoted a revived interest in stentless xenografts for 
aortic valve replacement, l' 2 Like freehand aortic allo- 
grafts, stentless bioprostheses adapt to the aortic root to 
mimic the anatomy of the native valve. This property is 
expected to allow for reduced mechanical stress on the 
valve leaflets, thereby controlling calcific degeneration of
the xenograft, and for improved hemodynamics, possibly 
affecting clinical outcome after aortic valve replace- 
ment.1, 2However, as the experience gathered with stent- 
less xenografts i recent and a variety of models has been 
introduced in the clinical practice, close monitoring of the 
shortcomings of these prostheses i warranted. 
Clinical summaries 
PATIENT 1. A 72-year-old woman with moderate aortic 
valve stenosis, severe regurgitation, and coronary artery 
disease underwent valve replacement with an O'Brien- 
Angell (Bravo Cardiovascular Model 300, CryoLife, Inc., 
Atlanta, Ga.) stentless porcine valve and myocardial re- 
vascularization with two coronary artery bypass grafts. A 
size 25 Bravo xenograft was sutured in a supraanular, 
infracoronary position with three running sutures of 3-0 
Prolene polypropylene (Ethicon, Inc., Somerville, N.J.) as 
described by O'Brien. 3 The postoperative course of the 
patient was marked by circulatory instability necessitating 
2 days of ventilation and inotropic support. The patient 
was discharged on the tenth postoperative day, with 
echocardiographic evidence of mild central regurgitation 
of the prosthesis. Six months later the patient started 
having recurrent effort dyspnea. A second echocardio- 
gram and angiogram showed moderate-to-severe aortic 
prosthetic valve regurgitation. At reoperation, 8 months 
after the original procedure, the xenograft valve leaflets 
were intact. The porcine aortic wall support of the valve, 
however, was torn for a length of about 1 cm at the level 
of the native noncoronary cusp, causing severe perivalvu- 
lar regurgitation (Fig. 1). The stentless valve was replaced 
with a size 25 Hancock II (Hancock Extracorporeal Inc., 
Anaheim, Calif.) stented xenograft. The postoperative 
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recovery of the patient was uneventful, with echocardio- 
graphic evidence of satisfactory prosthetic valve function 
at discharge. 
PATIENT 2. A 61-year-old woman with critical aortic 
stenosis (peak pressure gradient of 120 mm Hg) under- 
went vane replacement with a size 23 O'Brien-Angell 
stentless porcine xenograft, as described above) At dis- 
charge, on the sixth postoperative day, the echocardio- 
graphic function of the aortic prosthesis (peak pressure 
gradient of 4 mm Hg) was satisfactory. Five months after 
the operation, the patient started having chest pain and 
dyspnea. Doppler echocardiography disclosed a signifi- 
cant transprosthetic pressure gradient (36 mm Hg). Five 
months later, during a hospital admission for further 
diagnostic workup, the patient had an episode of syncope. 
A second catheterization revealed severe prosthetic valve 
obstruction (peak pressure gradient of 82 mm Hg) caused 
by restricted motion of the vane leaflets. At reoperation, 
!1 months after implantation of the stentless bioprosthe- 
Fig. 1. Postoperative upside-down view of the explanted 
xenograft in patient 1, showing the torn porcine aortic wall 
support of the valve. The original 5 mm long tear at the 
level of right noncoronary commissural pillar is evident 
(arrow). The larger tear at the base of the noncoronary 
cusp was produced during explantation of the xenograft. 
The vane leaflets are otherwise intact. 
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Fig. 2. Postoperative view of the explanted xenograft in 
patient 2. Distortion and stiffening of the valve leaflets 
owing to pannus, which fills two of the three valve cusps, 
is evident. 
sis, the aortic root and valve leaflets were found to be 
extensively covered and distorted by fibrous tissue over- 
growth (Fig. 2). Because of scarring, the aortic anulus was 
too narrow for an adequate sized prosthesis and a Nicks 
root enlargement procedure had to be performed to insert 
a size 23 Hancock II stented xenograft. Postoperative 
recovery was uneventful, with satisfactory function of the 
aortic bioprosthesis (peak pressure gradient of 16 mm Hg) 
at discharge chocardiography. 
Comment. Moving from the observation of longer du- 
ration of hand-sewn aortic homografts in the aortic root 
when compared to stent-mounted aortic valve ho- 
mografts, 1 a new generation of stentless xenograft valves 
has been developed that closely resemble freehand ho- 
mografts in structure and technique of implantation. ~' 2 
Owing to the ability to adapt o the aortic root in a more 
anatomic fashion, stentless xenografts are thought to 
dampen the mechanical stress to which the aortic valve 
leaflets are normally subjected. Inasmuch as mechanical 
stress has been recognized to be a major determinant of 
bioprosthetic failure, stentless valves are expected to be 
more durable than stent-mounted xenografts. 1 
A variety of structural and biologic factors, besides 
calcification, however, may affect durability of a biopros- 
thesis.4,5 The two cases reported herein document he 
occurrence of early (<12 months} structural failure with 
the O'Brien-Angell stentless porcine xenograft. The 
O'Brien-Angell stentless bioprosthesis is a composite 
valve constructed with noncoronary leaflets obtained from 
three porcine valves. The leaflets are sutured together 
along the free edges of the aortic wall at the leaflet 
commissures. Preliminary results with the O'Brien-Angell 
stentless aortic xenograft suggest the existence of a learn- 
ing curve, which tends to blunt after the first 50 implants. 2 
Satisfactory early results are thereafter eported with 
limited need for reoperation, credited primarily to tech- 
nical factors, a Our preliminary experience with 40 
O'Brien-Angell valves, out of the more than 170 aortic 
stentless xenograft implants, resembles that of Hvass and 
associates. 2 Whereas two of our earlv (<12 monthsl 
reoperations were clearly technique-related, the two rein- 
terventions described herein were caused by structural 
failure of the valve. In the first patient, tear of the porcine 
aortic wall support a few months after implantation. 
causing severe perivalvular regurgitation, could be attrib- 
uted to intraoperative trauma or uneven shear stress on 
the valve. The fibrous tissue overgrowth restricting leaflet 
opening in the second patient is a phenomenon well 
described with the standard stented xenograft valves and 
suggests the involvement of biologic reactions in the 
host.4. 5 Replacement of the xenograft valves was not 
exceedingly challenging, although in one patient he aortic 
anulus had to be enlarged because of scarring of the aortic 
root. 
Early @sfunction with the O'Brien-Angell freehand 
stentless aortic xenografts may occur as a result of struc- 
tural valve failure or fibrous tissue overgrowth. Given the 
existence of alternative substitutes for replacement of the 
diseased aortic valve, close scrutiny of the early and late 
shortcomings of stentless xenografts i still advised. 
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